Joshua Drumm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Valneva Receives EMA s Positive CHMP Opinion for its Chikungunya Vaccine

Valneva Receives EMA s Positive CHMP Opinion for its Chikungunya Vaccine
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomJoshua drummInstituto butantanRichard hatchettJuan carlos jaramilloHealth information for internationalOxford universityEuropean commissionCenters for diseaseVp global communications european investor relationsBrazilian health regulatory agencyEuropean unionCommittee for medicinal products human useHealth canada

Valneva Appoints Dr Hanneke Schuitemaker, Ph D as Chief

Valneva Appoints Dr Hanneke Schuitemaker, Ph D as Chief
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Noord hollandThomas lingelbachJoshua drummHanneke schuitemakerAmsterdam university medical centerNetherland blood supply foundationVp global communications european investor relationsEuronext parisChief scientific officerExecutive committeeExecutive teamGlobal headViral vaccine discoveryTranslational medicineChief executive officer

Valneva Appoints Dr Hanneke Schuitemaker, Ph D as Chief Scientific Officer

Valneva Appoints Dr Hanneke Schuitemaker, Ph D as Chief Scientific Officer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Noord hollandThomas lingelbachHanneke schuitemakerJoshua drummAmsterdam university medical centerNetherland blood supply foundationVp global communications european investor relationsEuronext parisChief scientific officerExecutive committeeExecutive teamGlobal headViral vaccine discoveryTranslational medicineChief executive officerFirst chikungunya vaccine

Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates

07.05.2024 - Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates Q1 financial highlights Total revenues of €32.8 million, including sales of €32.1 million, on track to meet anticipated full year guidance .

United kingdomUnited statesRabipur rabavertJoshua drummInstituto butantanFda tropical disease priority review voucher programCoalition for epidemic preparedness innovationsUs centers for diseaseGlobal communicationsUs advisory committee on immunization practicesDeerfield management companyExchange commissionThird partyPriority review voucherEuronext parisFinancial reports

Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates

Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates Q1 financial highlights Total revenues of €32.8 million, including sales of €32.1.

United kingdomUnited statesJoshua drummInstituto butantanFda tropical disease priority review voucher programExchange commissionDeerfield management companyGlobal communicationsTropical disease priority review voucher programUs centers for diseaseCoalition for epidemic preparedness innovationsUs advisory committee on immunization practicesThird partyValneva reports first quarterPriority review voucherEuronext paris